4.5 Interaction with other medicinal products and other forms of interaction  
 No interaction studies have been conducted with avelumab. 
 Avelumab is primarily metabolised through catabolic pathways, therefore, it is not expected that avelumab will have pharmacokinetic drug -drug interactions with other medicinal products.  
 9 